Some thoughts and a few prayers

Some thoughts and a few prayers

Before we get down to business our thoughts and prayers go out to all the good people of Mexico impacted by the earthquake and the good people of Puerto Rico (actually the entire Caribbean area) impacted by the recent hurricanes. And let’s not forget the people in Florida and Texas. While we don’t believe in such things we’d say the big guy upstairs is unhappy about something.

Sadly, there is a business angle to these events as Medtronic (NYSE: MDT) manufactures sensors and pumps in Puerto Rico and while it is still very early it is difficult to imagine this not impacting the company. Various reports coming out of the country state it will be MONTHS before the power is fully restored not to mention the impact the storm has on Medtronic employees. So, in addition to dealing with their recent infusion set recall and sensor shortage the company must now deal with the impact of something they nor anyone else could control.

One company that’s in completely different position is OneDrop who unfortunately has chosen not to control their propensity for stretching the truth. Two days ago, Dexcom (NASDAQ: DXCM) in a press release stated;

“DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring (CGM), announced today the availability of a public API, empowering third-party developers to connect patient-authorized CGM data into a broad range of software applications. This pioneering approach to CGM data sharing is intended to enable a rich ecosystem of novel solutions and put the user in control of where and how they interact with their glucose data.”

Further along in the release it states;

“Diabetes is a data-driven disease,” said Jeff Dachis, Founder and Chief Executive Officer of One Drop, a leading digital diabetes management solution and Dexcom API user. “By combining Dexcom data with One Drop’s ability to connect users, coaches and diabetes peers, this partnership will help drive innovation and will bring about more affordable, accessible, scalable, and effective solutions. It’s a big win for people with diabetes.”

As of today, developers in the US can register at and immediately access the Dexcom API. Several well-established companies and startups in the diabetes space including One Drop, Nutrino, Tidepool, Rimini, Deviation, Enda, and App Practice are already accessing the API for patient-approved CGM data retrieval.”

Please read the quote by Mr. Dachis as he states, “this partnership will help drive innovation”. Now we were a little taken aback by this statement as we did not believe that OneDrop and Dexcom were partners or at least what we think partners are and it turned out we were right. When we reached out to Dexcom they made it very clear THEY ARE NOT partnered with OneDrop in any way. When asked how they could classify the relationship the company stated that OneDrop and all the other companies mentioned in the release were collaborators but none were partners.

Now we aren’t surprised the folks at OneDrop are playing very fast and very loose with the facts as these are the same people who boost about self-reported results and try and pawn off this bullshit as evidence their whiz bang way cool toy works. The real surprise is a company as respectable as Dexcom would allow these con-artists a platform.

As long as were talking whiz bang way cool we were taken aback yesterday when we received the following text message;

“Hi from Livongo. We’ve missed getting your blood sugar readings. Can we help with anything? Please call us any time at “

We found this odd as we haven’t used the Livongo device in over TWO YEARS. If this wasn’t so damn funny it would be sad. We felt like calling back and telling the good people at Livongo that yes contrary to what some people may like we are alive and doing quite well. That we do appreciate their concern and do find it touching but it might be wise not to wait two years before asking why we are not using the damn thing.

Momma Kliff used to say all the time “You just can’t make this stuff up.”